263 related articles for article (PubMed ID: 33587920)
1. Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications.
Park D; Mabunga DFN; Adil KJ; Ryu O; Valencia S; Kim R; Kim HJ; Cheong JH; Kwon KJ; Kim HY; Han SH; Jeon SJ; Shin CY
Neuropharmacology; 2021 Apr; 187():108494. PubMed ID: 33587920
[TBL] [Abstract][Full Text] [Related]
2. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
[TBL] [Abstract][Full Text] [Related]
3. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
Garnock-Jones KP; Keating GM
Paediatr Drugs; 2009; 11(3):203-26. PubMed ID: 19445548
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
[TBL] [Abstract][Full Text] [Related]
6. Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice.
Sifeddine W; Ba-M'hamed S; Landry M; Bennis M
Pharmacol Rep; 2023 Apr; 75(2):342-357. PubMed ID: 36787018
[TBL] [Abstract][Full Text] [Related]
7. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP
Encephale; 2005; 31(3):337-48. PubMed ID: 16142049
[TBL] [Abstract][Full Text] [Related]
8. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
Schulz KP; Bédard AV; Fan J; Hildebrandt TB; Stein MA; Ivanov I; Halperin JM; Newcorn JH
J Am Acad Child Adolesc Psychiatry; 2017 Jul; 56(7):602-609.e2. PubMed ID: 28647012
[TBL] [Abstract][Full Text] [Related]
9. Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
Sangal RB; Owens J; Allen AJ; Sutton V; Schuh K; Kelsey D
Sleep; 2006 Dec; 29(12):1573-85. PubMed ID: 17252888
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
Bradshaw SE; Agster KL; Waterhouse BD; McGaughy JA
Brain Res; 2016 Jun; 1641(Pt B):245-57. PubMed ID: 26774596
[TBL] [Abstract][Full Text] [Related]
11. Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.
Harvey RC; Jordan CJ; Tassin DH; Moody KR; Dwoskin LP; Kantak KM
Behav Brain Res; 2013 May; 244():38-47. PubMed ID: 23376704
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine attenuates prepulse inhibition deficit induced by neonatal administration of MK-801 in mice.
Yang L; Liu F; Yuan Q; Zhu J; Wang W; Li X; He J
Neuroreport; 2020 Nov; 31(16):1128-1133. PubMed ID: 32956214
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate disrupts social play behavior in adolescent rats.
Vanderschuren LJ; Trezza V; Griffioen-Roose S; Schiepers OJ; Van Leeuwen N; De Vries TJ; Schoffelmeer AN
Neuropsychopharmacology; 2008 Nov; 33(12):2946-56. PubMed ID: 18305462
[TBL] [Abstract][Full Text] [Related]
14. Intracellular mechanisms and behavioral changes in mouse model of attention deficit hyperactivity disorder: Importance of age-specific NMDA receptor blockade.
Kawade HM; Borkar CD; Shambharkar AS; Singh O; Singru PS; Subhedar NK; Kokare DM
Pharmacol Biochem Behav; 2020 Jan; 188():172830. PubMed ID: 31756355
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine Reestablishes Long Term Potentiation in a Mouse Model of Attention Deficit/Hyperactivity Disorder.
Piña R; Rozas C; Contreras D; Hardy P; Ugarte G; Zeise ML; Rojas P; Morales B
Neuroscience; 2020 Jul; 439():268-274. PubMed ID: 31809728
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.
Simpson D; Plosker GL
CNS Drugs; 2004; 18(6):397-401. PubMed ID: 15089111
[TBL] [Abstract][Full Text] [Related]
17. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
[TBL] [Abstract][Full Text] [Related]
18. Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit/hyperactivity disorder.
Robinson AM; Eggleston RL; Bucci DJ
Behav Neurosci; 2012 Dec; 126(6):762-71. PubMed ID: 23067385
[TBL] [Abstract][Full Text] [Related]
19. Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.
Ota T; Iida J; Nakanishi Y; Sawada S; Matsuura H; Yamamuro K; Ueda S; Uratani M; Kishimoto N; Negoro H; Kishimoto T
Psychiatry Clin Neurosci; 2015 Mar; 69(3):161-70. PubMed ID: 25359429
[TBL] [Abstract][Full Text] [Related]
20. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
